DermaCure RT
DermaCureRT provides dermatology practices with a turn-key electronic brachytherapy solution, Skin eBx, powered by the Xoft System, which uses the world's smallest X-ray source to deliver precise, non-invasive radiation to treat non-melanoma skin cancer. This in-office treatment alternative to Mohs surgery allows patients to resume normal activities immediately with no downtime, and the system is FDA cleared and CE marked, with more than 10,000 patients successfully treated.
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Non-melanoma skin cancer, including basal cell and squamous cell carcinomas, accounts for approximately 90 percent of all skin cancers, with over 5.4 million cases diagnosed annually. Traditional treatment typically involves surgical removal, such as Mohs surgery, which can be invasive, require significant downtime, and may not be suitable for all patients or tumor locations.
Solution
DermaCureRT offers dermatology practices a turn-key electronic brachytherapy solution called Skin eBx, powered by the Xoft System, which uses the world's smallest X-ray source to deliver precise, concentrated radiation directly to the tumor site. This non-invasive treatment alternative to surgery allows patients to return to normal activities immediately with no downtime while achieving excellent cosmetic results. The system is FDA cleared, CE marked, and has successfully treated more than 10,000 patients with Skin eBx. DermaCureRT helps practices integrate this technology into their existing workflow without adding capital or operating costs, enabling physicians to expand their scope of services and handle higher patient volumes efficiently.
Target Audience
Primary customers are dermatology practices and dermatologists seeking to expand their treatment offerings for basal and squamous cell skin cancer patients, particularly those looking for non-surgical alternatives to Mohs surgery.
Features
- Electronic brachytherapy using a proprietary, isotope-free miniaturized X-ray source operating at 50 kV for high dose rate, low energy radiation
- Skin applicators ranging from 10mm to 50mm in size, providing physicians with maximum flexibility in treating various lesion sizes on the body
- Turn-key program that allows practices to offer advanced treatment options without significant capital investment or additional operating costs
- Xoft System delivers precise, concentrated radiation doses directly to the tumor site while minimizing damage to surrounding healthy tissue
- In-office treatment capability that enables patients to resume normal activities immediately following procedures
- Cure rates of 95% to 98% for electronic brachytherapy, comparable to Mohs surgery
- Treatment typically involves an average of 8 sessions over 4 weeks with no need for anesthesia